Category: Healthcare Quick infos Trade prices Volume: Market Cap: 11.78B Prev closed: 94.79 Open: 50.59 High: 58.84 Low: 47.12 52 week low: 36.15 52 week high: 151.8 Dividends: No Dividends Next ER: September 1, 2021
About the Company
CureVac N.V. is a biopharmaceutical company, legally domiciled in the Netherlands and headquartered in TÃ¼bingen, Germany, that develops therapies based on messenger RNA. The company's focus is on developing vaccines for infectious diseases and drugs to treat for cancer and rare diseases.
Date EPS / Forecast Revenue / Forecast December 6, 2021 September 1, 2021 - / -0.765 - / 12.25M August 16, 2021 -0.81 / -0.95 22M / 17.3M Beat! May 26, 2021 -0.615 / -0.61 10M / 12.35M April 15, 2021 -0.4 / - 6M / - Beat! view more Historical Data
Date Price Open High Low Vol Change ER Oct 12, 2021 40.28 37.61
1.56M -6.69% Oct 11, 2021 43.17 43.68
386.38K -1.37% Oct 8, 2021 43.77 43.89
250.57K -0.75% Oct 7, 2021 44.10 42.87
355.37K 3.30% Oct 6, 2021 42.69 43.05
548.72K -2.73% Oct 5, 2021 43.89 43.60
525.03K 1.36% Oct 4, 2021 43.30 45.00
1.26M -7.02% Oct 1, 2021 46.57 52.11
2.17M -14.74% Sep 30, 2021 54.62 54.22
300.05K -0.51% Sep 29, 2021 54.90 55.99
267.25K -2.1% view more
NASDAQ - Nasdaq Stock Market
News CureVac Started the Day Worth More Than Novavax. Then Its Vaccine News Hit. barrons.com Jun 17, 2021 7:31 pm CureVac Provides Update on Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV finance.yahoo.com Jun 17, 2021 5:00 pm Global tally of COVID-19 cases tops 138 million as CDC committee opts to extend pause on J&J vaccine marketwatch.com Jun 17, 2021 11:24 am CureVac to develop new variant vaccines for the U.K. marketwatch.com Jun 17, 2021 10:42 am Novartis Will Help Manufacture CureVacs Covid-19 Vaccine barrons.com Jun 17, 2021 10:17 am CureVacs COVID vaccine has important role to play in fighting variants, CEO says marketwatch.com Jun 17, 2021 10:16 am UPDATE 2-Drugmakers say Biden misguided over vaccine patent waiver finance.yahoo.com Jun 17, 2021 9:58 am CureVac Taps Celonic For COVID-19 Vaccine Production finance.yahoo.com Jun 17, 2021 9:27 am EU takes legal action against AstraZeneca over COVID vaccine contract finance.yahoo.com Jun 17, 2021 9:04 am CureVac's COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection Against SARS-CoV-2 B.1.351 Variant (South African Variant) in Preclinical Challenge Study finance.yahoo.com Jun 17, 2021 8:20 am CureVac Expands CVnCoV Covid-19 Vaccine Candidate Clinical Trial Analyses to Include Phase 2b/3 Variant Specification and Efficacy Secondary Endpoint to Phase 2a finance.yahoo.com Jun 17, 2021 8:15 am UPDATE 2-Novartis joins CureVac's vaccine contractor line-up finance.yahoo.com Jun 17, 2021 8:11 am Could CureVac Be a Millionaire-Maker Stock? fool.com Jun 17, 2021 8:10 am Dow Jones Futures Fall On Fed Rate-Hike Losses; Goldman In Buy Range, Covid Vaccine Play CureVac Crashes investors.com Jun 17, 2021 8:10 am The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision finance.yahoo.com Jun 17, 2021 7:31 am Inovio and CureVac Surge on Vaccine Candidate Results, J&J Pause thestreet.com Jun 17, 2021 6:51 am Tesla-Backed CureVac Plunges On Underwhelming COVID-19 Vaccine Efficacy Data finance.yahoo.com Jun 17, 2021 5:07 am Are Insiders Buying CureVac N.V. (NASDAQ:CVAC) Stock? finance.yahoo.com Jun 17, 2021 3:28 am CureVac Shares Leap On COVID Vaccine Pact With GlaxoSmithKline thestreet.com Jun 17, 2021 3:19 am What Type Of Shareholders Own The Most Number of CureVac N.V. (NASDAQ:CVAC) Shares? finance.yahoo.com Jun 17, 2021 2:47 am
This company doesn't provide a dividend.
Key Persons Chairman : Chairperson: Jean Stéphenne CEO : Ingmar Hoerr (Mar 2020–) Talk about CureVac NV below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
If you want to help pay for server cost or for improving this tool. You can send it via
Paypal. More features coming soon :) Buy on Amazon
Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis